» Articles » PMID: 34183730

Exploring the Chemical Space of Protein-protein Interaction Inhibitors Through Machine Learning

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jun 29
PMID 34183730
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Although protein-protein interactions (PPIs) have emerged as the basis of potential new therapeutic approaches, targeting intracellular PPIs with small molecule inhibitors is conventionally considered highly challenging. Driven by increasing research efforts, success rates have increased significantly in recent years. In this study, we analyze the physicochemical properties of 9351 non-redundant inhibitors present in the iPPI-DB and TIMBAL databases to define a computational model for active compounds acting against PPI targets. Principle component analysis (PCA) and k-means clustering were used to identify plausible PPI targets in regions of interest in the active group in the chemical space between active and inactive iPPI compounds. Notably, the uniquely defined active group exhibited distinct differences in activity compared with other active compounds. These results demonstrate that active compounds with regions of interest in the chemical space may be expected to provide insights into potential PPI inhibitors for particular protein targets.

Citing Articles

Machine Learning Models to Predict Protein-Protein Interaction Inhibitors.

Diaz-Eufracio B, Medina-Franco J Molecules. 2022; 27(22).

PMID: 36432086 PMC: 9694076. DOI: 10.3390/molecules27227986.


IFI44 is an immune evasion biomarker for SARS-CoV-2 and infection in patients with RA.

Zheng Q, Wang D, Lin R, Lv Q, Wang W Front Immunol. 2022; 13:1013322.

PMID: 36189314 PMC: 9520788. DOI: 10.3389/fimmu.2022.1013322.


In Silico Prediction of Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex.

Hafiz A, Bakri R, Alsaad M, Fetni O, Alsubaihi L, Shamshad H Pharmaceuticals (Basel). 2022; 15(6).

PMID: 35745611 PMC: 9230678. DOI: 10.3390/ph15060691.


A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.

Qvit N, Lin A, Elezaby A, Ostberg N, Campos J, Ferreira J Pharmaceuticals (Basel). 2022; 15(3).

PMID: 35337069 PMC: 8950820. DOI: 10.3390/ph15030271.


Aurora A and AKT Kinase Signaling Associated with Primary Cilia.

Nishimura Y, Yamakawa D, Shiromizu T, Inagaki M Cells. 2021; 10(12).

PMID: 34944109 PMC: 8699881. DOI: 10.3390/cells10123602.

References
1.
Guo W, Wisniewski J, Ji H . Hot spot-based design of small-molecule inhibitors for protein-protein interactions. Bioorg Med Chem Lett. 2014; 24(11):2546-54. DOI: 10.1016/j.bmcl.2014.03.095. View

2.
Gurung A, Bhattacharjee A, Ali M, Al-Hemaid F, Lee J . Binding of small molecules at interface of protein-protein complex - A newer approach to rational drug design. Saudi J Biol Sci. 2017; 24(2):379-388. PMC: 5272936. DOI: 10.1016/j.sjbs.2016.01.008. View

3.
Singh N, Guha R, Giulianotti M, Pinilla C, Houghten R, Medina-Franco J . Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J Chem Inf Model. 2009; 49(4):1010-24. PMC: 2686115. DOI: 10.1021/ci800426u. View

4.
Souers A, Leverson J, Boghaert E, Ackler S, Catron N, Chen J . ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013; 19(2):202-8. DOI: 10.1038/nm.3048. View

5.
Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View